# Janssen Biologics B.V. - Inspection Records

Source: https://www.keypedia.com/companies/janssen-biologics-bv/7a6ebdd7-85cd-43b7-89e6-39accf2da352

> Inspection records and compliance data for Janssen Biologics B.V. in None, None. Access full analysis and detailed observations.

---

## Details

- Name: Janssen Biologics B.V.
- FEI Number: 3038376013

## Related Documents

- [483 - Janssen Biologics B.V. - Unknown Date](https://www.keypedia.com/records/483/janssen-biologics-bv/9559ba82-0b04-44ff-aefd-5c27de571195) — source: FDA, date: Invalid Date

## Related Companies

- [Amazon.com, Inc.](https://www.keypedia.com/companies/amazoncom-inc/5fec7b0a-8946-4740-ba4f-8ef0d4468c97)
- [Akom Pharmaceuticals, Inc.](https://www.keypedia.com/companies/akom-pharmaceuticals-inc/ac503050-70db-46c3-accc-c945413cfae1)
- [MVRB2, LLC, d/b/a Kure CBD & Vape](https://www.keypedia.com/companies/mvrb2-llc-dba-kure-cbd-vape/123d78b8-feb0-4bce-a6bc-830f90c028b6)
- [Ecig Charleston LLC](https://www.keypedia.com/companies/ecig-charleston-llc/77ffeae0-3f8b-4dd4-8d0c-50046b9e2a93)
- [perrigo florida inc ](https://www.keypedia.com/companies/perrigo-florida-inc/1e078d10-8675-4ad5-a0ac-a7bcbdbc9fa4)
- [Bard Access Systems, Inc. (BAS)](https://www.keypedia.com/companies/bard-access-systems-inc-bas/69196e97-e99f-4ed1-9dae-6ef62e286361)
- [GVK Biosciences Pvt. Ltd.](https://www.keypedia.com/companies/gvk-biosciences-pvt-ltd/b9655de8-c18d-4572-9f8b-252e9ea89352)
- [Covance Laboratories Inc.](https://www.keypedia.com/companies/covance-laboratories-inc/5b73fa64-27e8-4603-9c2d-dc7aaae3d957)
- [fusion iv pharmaceuticals, inc. ](https://www.keypedia.com/companies/fusion-iv-pharmaceuticals-inc/c1ced97a-5665-4304-9421-6b2ff8df4615)
- [Vape.com](https://www.keypedia.com/companies/vapecom/0b7a62e7-a477-4483-9928-cebb786b4160)

## Related Officers

- [Sharmila Shrestha](https://www.keypedia.com/people/sharmila-shrestha/0a91aac0-76a5-4105-a23b-e0966f1aec0e)
- [investigator](https://www.keypedia.com/people/kevin-j-matthews/ee27a58a-3d45-4ac6-979f-7659067c11e6)
